EUVIMEDEUVIMED entdecken
Crossref

Edaravone mitigates calcium oxalate–induced renal tubular epithelial cell injury by inhibiting autophagy-mediated ferroptosis

Wei Chen, Zipei Cao, Shunping Wang

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03630-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Wei Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ningbo Urology and Nephrology Hospital, No.998 Qianhe North Road, Ningbo, 315100, Zhejiang, China. Hauptthemen laut MEDLINE: Ferroptosis, Autophagy, Calcium Oxalate, Epithelial Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Edaravone (EDA) has been found to exert protective effects on kidney injury. Nevertheless, the functions of EDA in kidney stones as well as the potential mechanism are vague. Calcium oxalate (CaOx) was used to induce kidney stones cell model with human renal tubular epithelial cell line HK-2. CCK-8 assay was employed to detect cell viability injury. Oxidative stress was measured by DCFH-DA staining and detection of MDA, SOD, and GSH. Staining of FerroOrange and western blot were applied for ferroptosis. In addition, autophagy was elucidated by western blot and immunofluorescence staining. The data showed that CaOx treatment aggravated HK-2 cell viability injury, increased the levels of ROS, MDA, and Fe2+ in HK-2 cells, and reduced the contents of SOD and GSH. Additionally, CaOx enhanced the expression of KIM1, TFR1, LC3II/LC31, and BECLIN1 in HK-2 cells, while resulting in a decrease in the expression of GPX4, SLC7A11, and P62. Pretreatment of EDA mitigated CaOx-induced oxidative stress and ferroptosis, as well as autophagy in renal tubular epithelial cells. However, autophagy inducer rapamycin (Rap) reversed the protective role of EDA on renal tubular epithelial cell injury, oxidative stress, and ferroptosis. In conclusion, EDA contributes to suppressing oxidative stress and ferroptosis in CaOx-induced HT22 cells by restraining autophagy, which may be a potential candidate for the treatment of kidney stones caused by renal tubular epithelial cell damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAutophagyCalcium OxalateEpithelial CellsEdaravoneKidney TubulesHumansCell LineOxidative StressCell Survival

Stichwörter der Autor:innen

AutophagyCalcium oxalateEdaravoneFerroptosisKidney stones

Substanzen

Calcium OxalateEdaravone

Autor:innen und Institutionen

  • Department of Urology, Ningbo Urology and Nephrology Hospital, No.998 Qianhe North Road, Ningbo, 315100, Zhejiang, China.
  • Department of Urology, Ningbo Urology and Nephrology Hospital, No.998 Qianhe North Road, Ningbo, 315100, Zhejiang, China. WangspSLFB@163.com.

Zitieren

APA

Chen, W., Cao, Z., & Wang, S. (2025). Edaravone mitigates calcium oxalate–induced renal tubular epithelial cell injury by inhibiting autophagy-mediated ferroptosis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03630-6

Vancouver

Chen W, Cao Z, Wang S. Edaravone mitigates calcium oxalate–induced renal tubular epithelial cell injury by inhibiting autophagy-mediated ferroptosis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03630-6

BibTeX
@article{Chen2025,
  author = {Chen, Wei and Cao, Zipei and Wang, Shunping},
  title = {Edaravone mitigates calcium oxalate–induced renal tubular epithelial cell injury by inhibiting autophagy-mediated ferroptosis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03630-6}
}
Kostenlos starten →